Research Publications

Longitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart study.

Consumer perceptions of direct-to-consumer personalized genomic risk assessments.

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial.

Pharmacy benefit managers, pharmacies, and pharmacogenomic testing: prescription for progress?

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial.

The case for routine genotyping in dual-antiplatelet therapy.

Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.

A genome-wide linkage scan identifies multiple quantitative trait loci for HDL-cholesterol levels in families with premature CAD and MI.

Accurate detection and genotyping of SNPs utilizing population sequencing data.

The consumer movement in health care.